Baxter 0.45% Sodium Chloride and 5% Glucose Intravenous Infusion 1000 mL bag (AHB6028) Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 5% glucose intravenous infusion 1000 ml bag (ahb6028)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 4.5 g/l - injection - excipient ingredients: water for injections; hydrochloric acid - sodium chloride and glucose intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 1000mL injection AHB1254 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 1000ml injection ahb1254

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 1000mL injection AHB1034 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 1000ml injection ahb1034

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.9% SODIUM CHLORIDE and 5% GLUCOSE 1000mL injection AHB1064 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.9% sodium chloride and 5% glucose 1000ml injection ahb1064

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.18% SODIUM CHLORIDE and 4% GLUCOSE 500mL injection AHB1253 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.18% sodium chloride and 4% glucose 500ml injection ahb1253

baxter healthcare pty ltd - glucose, quantity: 40 g/l; sodium chloride, quantity: 1.8 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.225% SODIUM CHLORIDE and 3.75% GLUCOSE 500mL Injection BP AHB1243 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.225% sodium chloride and 3.75% glucose 500ml injection bp ahb1243

baxter healthcare pty ltd - glucose, quantity: 37.5 g/l; sodium chloride, quantity: 2.25 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.3% SODIUM CHLORIDE and 3.3% GLUCOSE 500mL injection AHB1033 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.3% sodium chloride and 3.3% glucose 500ml injection ahb1033

baxter healthcare pty ltd - glucose, quantity: 33 g/l; sodium chloride, quantity: 3 g/l - injection, solution - excipient ingredients: water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.45% SODIUM CHLORIDE and 2.5% GLUCOSE 500mL injection AHB1023 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.45% sodium chloride and 2.5% glucose 500ml injection ahb1023

baxter healthcare pty ltd - glucose, quantity: 25 g/l; sodium chloride, quantity: 4.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - sodium chloride (%) and glucose (%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of sodium and chloride ion concentrations. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

Pemetrexed Baxter European Union - English - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5.1).pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.1).

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.